A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination
CompletedOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
May 1, 2019
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Conditions
COPDCOPD Exacerbation
Trial Locations (1)
Unknown
Papanikolaou Hospital of Thessaloniki, Thessaloniki